Drug recall · September 1, 2021
Atovaquone Oral Suspension recall
Why: Temperature abuse: the firm received customer complaints of unusual grittiness in the product.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Atovaquone Oral Suspension, USP, 750 mg/5 mL, 210 mL bottle, Rx Only, Mfd. By: KVK-Tech, Inc., Newtown, PA 18940, NDC 10702-223-21.
- Lots / codes
Batch # 16653A, 16654A, Exp 12/2022
- Quantity
- 1,692 bottles
- Company
- KVK-Tech, Inc., Newtown, PA
- Distribution
- Product was distributed to one distributor who may have further distributed Nationwide in the USA.
- Initiated
- July 2, 2021 · Voluntary: Firm initiated
- Classified
- August 26, 2021
- Reported
- September 1, 2021
- Ended
- May 23, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Atovaquone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.